We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,370
Increased
1,985
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NE icon
976
Noble Corp
NE
$6.45B
$414K 0.01%
14,642
+14,579
+23,141% +$413K
CMPR icon
977
Cimpress
CMPR
$2.4B
$413K 0.01%
6,552
+6,519
+19,755% +$365K
JXN icon
978
Jackson Financial
JXN
$8.8B
$410K 0.01%
4,050
+2,110
+109% +$197K
ICUI icon
979
ICU Medical
ICUI
$4.32B
$409K 0.01%
3,412
+3,203
+1,533% +$406K
EBAY icon
980
eBay
EBAY
$47.6B
$409K 0.01%
4,500
+2,893
+180% +$256K
HLI icon
981
Houlihan Lokey
HLI
$8.77B
$409K 0.01%
1,992
+1,931
+3,166% +$379K
CHI
982
Calamos Convertible Opportunities and Income Fund
CHI
$1.03B
$408K 0.01%
37,854
-3,760
-9% -$39.4K
AGCO icon
983
AGCO
AGCO
$7.28B
$408K 0.01%
3,811
+3,729
+4,548% +$412K
APPN icon
984
Appian
APPN
$2.03B
$406K 0.01%
13,296
+13,284
+110,700% +$399K
BXP icon
985
Boston Properties
BXP
$11.2B
$406K 0.01%
5,458
+5,190
+1,937% +$366K
SRPT icon
986
Sarepta Therapeutics
SRPT
$1.68B
$405K 0.01%
21,005
+20,945
+34,908% +$373K
GSY icon
987
Invesco Ultra Short Duration ETF
GSY
$3.89B
$403K 0.01%
8,022
+3,668
+84% +$184K
USLM icon
988
United States Lime & Minerals
USLM
$3.21B
$402K 0.01%
+3,056
New +$353K
ACMR icon
989
ACM Research
ACMR
$5.43B
$401K 0.01%
+10,241
New +$304K
DOX icon
990
Amdocs
DOX
$5.88B
$399K 0.01%
4,861
+4,602
+1,777% +$399K
EVER icon
991
EverQuote
EVER
$852M
$399K 0.01%
17,437
+17,250
+9,225% +$417K
KURA icon
992
Kura Oncology
KURA
$816M
$397K 0.01%
+44,877
New +$320K
MYE icon
993
Myers Industries
MYE
$1.38B
$397K 0.01%
23,417
+23,273
+16,162% +$370K
NTB icon
994
Bank of N.T. Butterfield & Son
NTB
$2.46B
$395K 0.01%
9,205
+8,201
+817% +$370K
MBWM icon
995
Mercantile Bank Corp
MBWM
$1.05B
$395K 0.01%
8,768
+8,684
+10,338% +$413K
OSBC icon
996
Old Second Bancorp
OSBC
$1.31B
$394K 0.01%
22,813
+21,507
+1,647% +$387K
ALSN icon
997
Allison Transmission
ALSN
$9.65B
$394K 0.01%
4,637
+3,251
+235% +$289K
KFY icon
998
Korn Ferry
KFY
$4.21B
$393K 0.01%
5,615
+5,408
+2,613% +$394K
CSW
999
CSW Industrials
CSW
$5.6B
$390K 0.01%
1,605
+1,586
+8,347% +$426K
LEN icon
1000
Lennar Class A
LEN
$20.5B
$389K 0.01%
3,131
+2,831
+944% +$351K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,370 new positions and adding to 1,985 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,370 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.